{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:28:54Z","timestamp":1794666534030,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rmed.2025.108007","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:01:20Z","timestamp":1740168080000},"page":"108007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Epidemiology, disease burden of pulmonary arterial hypertension in China: A systematic literature review"],"prefix":"10.1016","volume":"240","author":[{"given":"Caojin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8831-2345","authenticated-orcid":false,"given":"Helen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena R.","family":"Ramey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Lautsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2025.108007_bib1","first-page":"538","article-title":"Pulmonary hypertension definition, classification, and epidemiology in Asia","volume":"2","author":"Anderson","year":"2022","journal-title":"JACC (J. Am. Coll. Cardiol.): Asia"},{"key":"10.1016\/j.rmed.2025.108007_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-013-0397-5","article-title":"Epidemiology of pulmonary arterial hypertension","volume":"15","author":"Jiang","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"issue":"38","key":"10.1016\/j.rmed.2025.108007_bib3","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2025.108007_bib4","author":"Rubin"},{"key":"10.1016\/j.rmed.2025.108007_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/resp.14247","article-title":"Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: insights from a national multicentre prospective registry","volume":"27","author":"Quan","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2025.108007_bib6","series-title":"Chinese Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension","year":"2021"},{"issue":"8","key":"10.1016\/j.rmed.2025.108007_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40273-016-0395-y","article-title":"Systematic review of health-related quality of life in patients with pulmonary arterial hypertension","volume":"34","author":"S","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.rmed.2025.108007_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40273-015-0361-0","article-title":"Systematic review of the economic burden of pulmonary arterial hypertension","volume":"34","author":"S","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.rmed.2025.108007_bib9","unstructured":"Wells GA SB, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.rmed.2025.108007_bib10","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Jonathan","year":"2019","journal-title":"Br. Med. J."},{"key":"10.1016\/j.rmed.2025.108007_bib11","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Jonathan","year":"2016","journal-title":"Br. Med. J."},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2025.108007_bib12","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J. Anaesth."},{"issue":"6","key":"10.1016\/j.rmed.2025.108007_bib13","first-page":"905","article-title":"Clinical and imaging analysis of pulmonary hypertension secondary to connective tissue disease-associated interstitial lung disease","volume":"30","author":"Yan","year":"2018","journal-title":"West. Med."},{"key":"10.1016\/j.rmed.2025.108007_bib14","article-title":"Analysis of the incidence of pulmonary hypertension and its risk factors in patients with congenital heart disease","volume":"2014","author":"Wen","year":"2014","journal-title":"Chinese Heart Congress"},{"issue":"9","key":"10.1016\/j.rmed.2025.108007_bib15","first-page":"770","article-title":"Clinical features of primary dry syndrome combined with pulmonary hypertension","volume":"13","author":"Xuemei","year":"2014","journal-title":"Chinese Journal of General Practitioner"},{"issue":"2","key":"10.1016\/j.rmed.2025.108007_bib16","first-page":"179","article-title":"Clinical analysis of 59 cases of connective tissue disease-associated pulmonary hypertension","volume":"32","author":"Li","year":"2013","journal-title":"Journal of Cardiopulmonary Vascular Disease"},{"issue":"3","key":"10.1016\/j.rmed.2025.108007_bib17","first-page":"57","article-title":"Clinical discussion on connective tissue disease-associated pulmonary hypertension","volume":"10","author":"Liu","year":"2016","journal-title":"China Modern Drug Application"},{"issue":"4","key":"10.1016\/j.rmed.2025.108007_bib18","first-page":"258","article-title":"Retrospective analysis of connective tissue disease combined with pulmonary hypertension by echocardiography","volume":"29","author":"Hongxia","year":"2018","journal-title":"Chinese Journal of Clinical Medical Imaging"},{"issue":"26","key":"10.1016\/j.rmed.2025.108007_bib19","first-page":"58","article-title":"Clinical analysis of connective tissue disease-associated pulmonary hypertension","volume":"5","author":"Pang","year":"2017","journal-title":"Electronic Journal of Integrative Cardiovascular Disease in Chinese and Western Medicine"},{"issue":"10","key":"10.1016\/j.rmed.2025.108007_bib20","first-page":"1435","article-title":"Analysis of the clinical characteristics of pulmonary hypertension associated with polyarteritis obliterans","volume":"10","author":"Jin","year":"2015","journal-title":"Chin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108007_bib21","first-page":"39","article-title":"Clinical diagnosis and treatment of 58 cases of acute pulmonary thromboembolism","volume":"34","author":"Lv","year":"2014","journal-title":"Clin. Med."},{"issue":"11","key":"10.1016\/j.rmed.2025.108007_bib24","first-page":"125","article-title":"Analysis of risk factors and pharmacological treatment of portal hypertension in HBV cirrhotic liver","volume":"28","author":"Ma","year":"2016","journal-title":"Straits Pharmacol."},{"issue":"27","key":"10.1016\/j.rmed.2025.108007_bib25","first-page":"84","article-title":"Clinical characteristics and prognosis of liver transplant recipients with combined portal pulmonary hypertension","volume":"57","author":"Jian","year":"2017","journal-title":"Shandong Med"},{"issue":"4","key":"10.1016\/j.rmed.2025.108007_bib26","first-page":"322","article-title":"Analysis of clinical characteristics and risk factors in patients with cirrhotic portal hypertension combined with pulmonary hypertension","volume":"43","author":"Huang","year":"2023","journal-title":"Chinese Journal of Practical Internal Medicine"},{"issue":"10","key":"10.1016\/j.rmed.2025.108007_bib27","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/cid\/ciu086","article-title":"Prospective echocardiographic assessment of cardiac structure and function in Chinese persons living with HIV","volume":"58","author":"Luo","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2025.108007_bib28","first-page":"367","article-title":"Oxygen uptake efficiency slope predicts prognosis in idiopathic pulmonary hypertension","volume":"32","author":"Tang","year":"2017","journal-title":"Chinese Journal of Circulation"},{"issue":"19","key":"10.1016\/j.rmed.2025.108007_bib29","first-page":"1507","article-title":"Application value of electrocardiography in the treatment and prognosis of idiopathic pulmonary hypertension","volume":"25","author":"Gong","year":"2019","journal-title":"J. Hainan Med. Coll."},{"issue":"9","key":"10.1016\/j.rmed.2025.108007_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045165","article-title":"Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China","volume":"11","author":"Luo","year":"2021","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.rmed.2025.108007_bib31","first-page":"4070","article-title":"Surgical management strategy and outcome analysis of adult congenital heart disease combined with severe pulmonary hypertension","volume":"9","author":"Fang","year":"2015","journal-title":"Chin. J. Clin."},{"issue":"7","key":"10.1016\/j.rmed.2025.108007_bib32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.healun.2023.02.1494","article-title":"Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: insights from a national multicenter prospective registry","volume":"42","author":"Xie","year":"2023","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108007_bib33","first-page":"66","article-title":"Effect of gender differences in cardiopulmonary exercise test parameters on event-free survival in patients with idiopathic pulmonary hypertension","volume":"39","author":"Tian-Xiang","year":"2018","journal-title":"J. Tongji Univ. Nat. Sci."},{"issue":"21","key":"10.1016\/j.rmed.2025.108007_bib34","first-page":"2284","article-title":"Role of N-terminal pro-brain natriuretic peptide in assessing the prognosis of patients with connective tissue disease combined with pulmonary hypertension","volume":"41","author":"Kim","year":"2019","journal-title":"Zhejiang Med"},{"issue":"5","key":"10.1016\/j.rmed.2025.108007_bib35","first-page":"573","article-title":"Postoperative respiratory support for low-body-mass infants with congenital heart disease and pulmonary hypertension","volume":"24","author":"Peng","year":"2015","journal-title":"Journal of Localised Surgery"},{"issue":"5","key":"10.1016\/j.rmed.2025.108007_bib36","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/1756-185X.13478","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR\u2010PAH study: baseline characteristics and risk factors","volume":"22","author":"Zhang","year":"2019","journal-title":"International journal of rheumatic diseases"},{"issue":"11","key":"10.1016\/j.rmed.2025.108007_bib37","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/rheumatology\/kead103","article-title":"10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry","volume":"62","author":"Chen","year":"2023","journal-title":"Rheumatology"},{"issue":"Supplement_2","key":"10.1016\/j.rmed.2025.108007_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac544.2642","article-title":"Risk stratification for systemic lupus erythematosus associated pulmonary hypertension by simplified ESC\/ERS guidelines: data from SOPHIE registry","volume":"43","author":"Zhou","year":"2022","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.rmed.2025.108007_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1164\/rccm.201207-1290OC","article-title":"Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension","volume":"187","author":"Wu","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108007_bib40","first-page":"641","article-title":"Survey on the current status and etiological composition of patients with pulmonary hypertension","volume":"42","author":"Lei","year":"2017","journal-title":"J. Cent. S. Univ."},{"issue":"11","key":"10.1016\/j.rmed.2025.108007_bib41","first-page":"1111","article-title":"A survey of survival status of patients with arterial pulmonary hypertension in China","volume":"37","author":"Luo","year":"2022","journal-title":"Chinese Journal of Circulation"},{"issue":"7","key":"10.1016\/j.rmed.2025.108007_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/resp.14247","article-title":"Characteristics, goal\u2010oriented treatments and survival of pulmonary arterial hypertension in China: insights from a national multicentre prospective registry","volume":"27","author":"Quan","year":"2022","journal-title":"Respirology"},{"issue":"18","key":"10.1016\/j.rmed.2025.108007_bib43","first-page":"1410","article-title":"The value of the COMPERA 2.0 scoring model in the prognostic assessment of Chinese patients with arterial pulmonary hypertension","volume":"103","author":"Yansholtz","year":"2023","journal-title":"Chin. Med J"},{"issue":"2","key":"10.1016\/j.rmed.2025.108007_bib44","first-page":"258","article-title":"Analysis of risk factors associated with pulmonary hypertension in systemic lupus erythematosus","volume":"53","author":"Chen","year":"2018","journal-title":"Journal of Anhui Medical University"},{"issue":"5","key":"10.1016\/j.rmed.2025.108007_bib45","first-page":"19","volume":"18","year":"2019","journal-title":"Journal of Anhui Institute of Health Professions and Technology."},{"issue":"4","key":"10.1016\/j.rmed.2025.108007_bib46","first-page":"334","article-title":"Factors affecting pulmonary hypertension in adult patients with atrial septal defects and the relationship between pulmonary artery pressure and pulmonary hypertension in the immediate post-interventional occlusion period","volume":"50","author":"Yuan","year":"2022","journal-title":"Journal of Clinical Military Medicine"},{"key":"10.1016\/j.rmed.2025.108007_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(24)00295-9","article-title":"Global, regional, and national burden of pulmonary arterial hypertension, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"13","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108007_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:16:44Z","timestamp":1762337804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"alternative-id":["S0954611125000691"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108007","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, disease burden of pulmonary arterial hypertension in China: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108007"}}